Exelixis Inc. diskutieren
Exelixis Inc.
WKN: 936718 / Symbol: EXEL / Name: Exelixis / Aktie / Biotechnologie & medizinische Forschung / Mid Cap /
39,90 €
1,29 %
Exelixis (NASDAQ:EXEL) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Ratings data for EXEL provided by MarketBeat
Exelixis (NASDAQ:EXEL) had its price target raised by analysts at HC Wainwright from $49.00 to $52.00. They now have a "buy" rating on the stock.
Ratings data for EXEL provided by MarketBeat
Exelixis (NASDAQ:EXEL) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $52.00 price target on the stock.
Ratings data for EXEL provided by MarketBeat
Exelixis (NASDAQ:EXEL) was upgraded by analysts at Wall Street Zen from a "buy" rating to a "strong-buy" rating.
Ratings data for EXEL provided by MarketBeat
Exelixis (EXEL) had its "buy" rating reaffirmed by TD Cowen.
Ratings data for EXEL provided by MarketBeat
Exelixis (EXEL) had its price target raised by HC Wainwright from $54.00 to $56.00. They now have a "buy" rating on the stock.
Ratings data for EXEL provided by MarketBeat
Neueste Beiträge
Berenberg_Bank in ASML Holding N.V. ADR diskutieren